In patients with left main coronary artery disease bypass surgery is the golf standard. Angioplasty is increasingly being used as an alternative. The PRECOMBAT trial, randomly assigned 600 such patients to either drug-eluting stents or bypass surgery. At one year, the rate of major adverse cardiac or cerebrovascular events (death from any cause, heart attack, paralysis, or ischemia-driven target vessel revascularization) was similar in both groups.
Source: N Engl J Med 2011; 364:1718.
No comments:
Post a Comment